Wen Li

Central South University — China

Medicine · Health Sciences

29h-index3.7kcitations156works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(24), Lung Cancer Treatments and Mutations(23), COVID-19 Clinical Research Studies(12), Chronic Obstructive Pulmonary Disease (COPD) Research(11), Pancreatic and Hepatic Oncology Research(11)

Publications155 total

Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral blood
Nature Communications·2025Open Access
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial
The Lancet Respiratory Medicine·2025· 1 cited
Lysosomal acidity and cathepsin L activate eosinophils via ARG1-mediated arginine metabolism in allergic airway inflammation
Nature Communications·2025Open Access
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
Nature Reviews Clinical Oncology·2025· 3 cited
Safety of osimertinib in Chinese patients with non-small cell lung cancer: a multi-center, prospective, observational study
Future Oncology·2025
Targeting glutamine catabolism suppresses eosinophil expansion and activation to alleviate allergic airway inflammation
Biochemical Pharmacology·2025
Fatty acid synthase-mediated lipid droplet formation enhances macrophage killing of Staphylococcus aureus
Cell Death and Disease·2025Open Access
Single Cell Omics Identify an Anti-Inflammatory Niche in Macrophages of Mild to Moderate COPD
American Journal of Respiratory Cell and Molecular Biology·2025
SCAP/SREBP2-Mediated Cholesterol Biosynthetic Pathway Suppresses Particulate Matter-Induced Macrophage Activation and Airway Inflammation
Journal of Inflammation Research·2025Open Access
Physiological Level of Eosinophils Is Essential for the Regeneration and Homeostasis of Murine Hematopoietic Stem Cells
Allergy·2025
Respiratory emerging viruses and drug resistance in lung cancer: challenges and new perspectives in treatment
Molecular Aspects of Medicine·2025· 1 cited
Global burden and characterization of hypertriglyceridemia-induced acute pancreatitis: results from a systematic review and a multi-center cohort study
Science China Life Sciences·2025· 6 citedOpen Access
Research on measurement of grounding resistance of transmission tower based on hybrid genetic algorithm
Journal of Physics Conference Series·2025Open Access
Successful aging rates of global older adults: A subgroup meta-analysis
Archives of Gerontology and Geriatrics·2025· 3 cited
A phase 2 study of HLX07 plus serplulimab with or without chemotherapy versus serplulimab plus chemotherapy as first-line therapy in advanced squamous non-small cell lung cancer.
Journal of Clinical Oncology·2025
Natural surgical risks and age distribution in Chinese patients with Peutz-Jeghers syndrome: Real-world research based on a web survey
World Journal of Gastrointestinal Surgery·2025· 2 citedOpen Access
Ocular manifestations in pediatric tumor suppressor gene mutations: a case series and literature review of RB1, NF1, NF2, VHL, and TSC
BMC Pediatrics·2025Open Access
Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation
Cell Reports Medicine·2025· 4 citedOpen Access
PICH deficiency attenuates the progression of lung adenocarcinoma and disrupts the DNA damage response
Clinical and Translational Medicine·2025Open Access
Abstract CT053: Aumolertinib with or without chemotherapy as first line treatment in locally advanced or metastatic NSCLC with sensitizing EGFR mutations (AENEAS2)
Cancer Research·2025· 3 cited
page 1 of 8Next →

Frequent Co-authors

Huahao Shen(22), Zhihua Chen(19), Songmin Ying(14), Yang Xia(8), Tianwen Lai(7), Huahao Shen(7), Fugui Yan(6), Fei Li(5), Kian Fan Chung(4), Dongqing Lv(4), Yun Zhao(4), Chao Cao(4), Chen Zhu(4), Hua Wen(4), Zhengqiang Bao(4), Fen Lan(4), Lin Wu(4), Chengzhi Zhou(4), Yinfang Wu(4), Yongchang Zhang(4)